rdm-site.ru


Bluebird Bio Stock Forecast

A biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Track Bluebird bio Inc (BLUE) Stock Price, Quote, latest community messages, chart, news and other stock related information. Bluebird Bio is a development-stage biotechnology company focused on gene therapy, gene editing, and cancer immunotherapy. bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene. On average, Wall Street analysts predict that Bluebird Bio's share price could reach $ by Aug 15, The average Bluebird Bio stock price prediction.

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. For the upcoming trading day on Wednesday, 4th we expect bluebird bio to open at $, and during the day (based on 14 day Average True Range), to move. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ What is the Bluebird bio stock price / share price today? The Bluebird bio stock price is USD today. Will BLUE stock price drop / fall? Yes. Bluebird is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over %. bluebird bio (BLUE) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. The 24 analysts offering price forecasts for bluebird bio have a median target of , with a high estimate of and a low estimate of The median. Bluebird bio Inc (BLUE) · Volume: 6,, · Bid/Ask: / · Day's Range: - The average one-year price target for bluebird bio, Inc. is $ The forecasts range from a low of $ to a high of $ bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases.

Get bluebird bio Inc (BLUE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Find the latest bluebird bio, Inc. (BLUE) stock quote, history, news and other vital information to help you with your stock trading and investing. According to our current BLUE stock forecast, the value of bluebird bio shares will rise by % and reach $ per share by September 10, Per our. The average stock forecast for bluebird bio Inc (BLUE) in the next 12 months is USD. This price target corresponds to an upside of %. The range of. The 9 analysts with month price forecasts for bluebird bio stock have an average target of , with a low estimate of and a high estimate of Is bluebird bio Stock Undervalued? The current bluebird bio [BLUE] share price is $ The Score for BLUE is 2, which is 96% below its historic median. See bluebird bio, Inc. (BLUE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for bluebird bio is $, with a. While ratings are subjective and will change, the latest bluebird bio (BLUE) rating was a maintained with a price target of $ to $ The current price.

Tomorrow's movement Prediction of Bluebird Bio, Inc. BLUE appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this. The average price target is $ with a high estimate of $6 and a low estimate of $3. Sign in to your SmartPortfolio to see more analyst recommendations. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. bluebird bio Stock (NASDAQ: BLUE) stock price, news, charts, stock research, profile. Bluebird bio (BLUE) stock price prediction is USD. The Bluebird bio stock forecast is USD for September 03, Wednesday;.

Making Money In Forex Trading | How To Do A Balance Transfer On American Express

35 36 37 38 39


Copyright 2015-2024 Privice Policy Contacts